Adaptive immune response during acute pancreatitis is regulated by NLRP3 inflammasome activation via interleukin 18

Pancreatology ◽  
2018 ◽  
Vol 18 (4) ◽  
pp. S87-S88
Author(s):  
Matthias Sendler ◽  
Cindy van den Brandt ◽  
Juliane Glaubitz ◽  
Anika Wilden ◽  
F. Ulrich Weiss ◽  
...  
2020 ◽  
Vol 2020 ◽  
pp. 1-11
Author(s):  
Kristine Midtbö ◽  
Daniel Eklund ◽  
Eva Särndahl ◽  
Alexander Persson

Inflammasomes cleave and activate interleukin- (IL-) 1β and IL-18 which have both shared and unique biological functions. IL-1β is an important mediator of the acute phase response to infections and tissue damage, whereas IL-18 takes part in activation and tailoring of the adaptive immune response. While IL-1β has served as the prototypic indicator of inflammasome activation, few studies have compared the potential differences in IL-1β and IL-18 production during inflammasome activation. Since these cytokines partake in different immune pathways, the involvement of inflammasome activity in different conditions needs to be described beyond IL-1β production alone. To address a potential heterogeneity in inflammasome functionality, ATP, chitosan, or silica oxide (SiO2) were used to induce NLRP3 inflammasome activation in THP-1 cells and the subsequent outcomes were quantified. Despite using doses of the inflammasome inducers yielding similar release of IL-1β, SiO2-stimulated cells showed a lower concentration of released IL-18 compared to ATP and chitosan. Hence, the cells stimulated with SiO2 responded with a distinctly different IL-18 : IL-1β ratio. The difference in the IL-18 : IL-1β ratio for SiO2 was constant over different doses. While all downstream responses were strictly dependent on a functional NLRP3 inflammasome, the differences did not depend on the level of gene expression, caspase-1 activity, or pyroptosis. We suggest that the NLRP3 inflammasome response should be considered a dynamic process, which can be described by taking the ratio between IL-1β and IL-18 into account and moving away from an on/off perspective of inflammasome activation.


Pancreatology ◽  
2017 ◽  
Vol 17 (3) ◽  
pp. S23-S24
Author(s):  
Matthias Sendler ◽  
Cindy van den Brandt ◽  
Weiss Frank-Ulrich ◽  
Janine Golchert ◽  
Georg Homuth ◽  
...  

2019 ◽  
Vol 75 ◽  
pp. 105821 ◽  
Author(s):  
Hong-zhong Jin ◽  
Xiao-jia Yang ◽  
Kai-liang Zhao ◽  
Fang-chao Mei ◽  
Yu Zhou ◽  
...  

Pancreatology ◽  
2020 ◽  
Vol 20 ◽  
pp. S55
Author(s):  
M. Zorniak ◽  
I. Regel ◽  
M. Sendler ◽  
G. Beyer ◽  
U. Mahajan ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (10) ◽  
pp. 2297
Author(s):  
Sonia Missiroli ◽  
Mariasole Perrone ◽  
Caterina Boncompagni ◽  
Chiara Borghi ◽  
Alberto Campagnaro ◽  
...  

Inflammasomes are multiprotein complexes that regulate the maturation and secretion of the proinflammatory cytokines interleukin-1beta (IL-1βand interleukin-18 (IL-18) in response to various intracellular stimuli. As a member of the inflammasomes family, NLRP3 is the most studied and best characterized inflammasome and has been shown to be involved in several pathologies. Recent findings have made it increasingly apparent that the NLRP3 inflammasome may also play a central role in tumorigenesis, and it has attracted attention as a potential anticancer therapy target. In this review, we discuss the role of NLRP3 in the development and progression of cancer, offering a detailed summary of NLRP3 inflammasome activation (and inhibition) in the pathogenesis of various forms of cancer. Moreover, we focus on the therapeutic potential of targeting NLRP3 for cancer therapy, emphasizing how understanding NLRP3 inflammasome-dependent cancer mechanisms might guide the development of new drugs that target the inflammatory response of tumor-associated cells.


2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Jian-Dong Ren ◽  
Jie Ma ◽  
Jun Hou ◽  
Wen-Jin Xiao ◽  
Wei-Hua Jin ◽  
...  

Increasing evidence has demonstrated that reactive oxygen species (ROS) induces oxidative stress and plays a crucial role in the pathogenesis of acute pancreatitis (AP). Hydrogen-rich saline (HRS), a well-known ROS scavenger, has been shown to possess therapeutic benefit on AP in many animal experiments. Recent findings have indicated that the NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome, an intracellular multiprotein complex required for the maturation of interleukin- (IL-) 1β, may probably be a potential target of HRS in the treatment of AP. Therefore, in this study, we evaluated the activation of NLRP3 inflammasome and meanwhile assessed the degree of oxidative stress and inflammatory cascades, as well as the histological alterations in mice suffering from cerulein-induced AP after the treatment of HRS. The results showed that the activation of NLRP3 inflammasome in AP mice was substantially inhibited following the administration of HRS, which was paralleled with the decreased NF-κB activity and cytokines production, attenuated oxidative stress and the amelioration of pancreatic tissue damage. In conclusion, our study has, for the first time, revealed that inhibition of the activation of NLRP3 inflammasome probably contributed to the therapeutic potential of HRS in AP.


2015 ◽  
Vol 125 (3) ◽  
pp. 1329-1338 ◽  
Author(s):  
Prajwal Gurung ◽  
Rajendra Karki ◽  
Peter Vogel ◽  
Makiko Watanabe ◽  
Mark Bix ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document